Noveris Health Sciences Inc.'s latest marketcap:
As of 08/31/2026, Noveris Health Sciences Inc.'s market capitalization has reached $298,629.84. According to our data, Noveris Health Sciences Inc. is the 51675th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 298,629.84 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 1.16 M |
| Shares Out | 1.24 M |
| EPS (ttm) | 0.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/03/2026 |
Noveris Health Sciences Inc.'s yearly market capitalization.
| Date | Market Cap(C$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2026 | C$407,570 | $298,629.84 | 30483.86% | 51675 |
| 12/23/2025 | C$382,869 | $273,575.56 | -38% | n/a |
| 12/31/2024 | C$617,554 | $429,076.52 | -41.26% | n/a |
| 12/29/2023 | C$1.05 M | $793,137.69 | -82.03% | n/a |
| 12/30/2022 | C$5.85 M | $4.32 M | -83.98% | n/a |
| 12/31/2021 | C$36.53 M | $28.88 M | n/a |
Company Profile
Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions.
The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs.
The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds.
Mydecine Innovations Group Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026.
The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Frequently Asked Questions
-
What is Noveris Health Sciences Inc.'s (CSE-NVRS) current market cap?As of 08/31/2026, Noveris Health Sciences Inc. (including the parent company, if applicable) has an estimated market capitalization of $298,629.84 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Noveris Health Sciences Inc. (CSE-NVRS) rank globally by market cap?Noveris Health Sciences Inc. global market capitalization ranking is approximately 51675 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.